ELAN
Elanco Animal Health Incorporated
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · US
$24.31
−0.45%Forward multiples
Based on analyst estimates
- P/E forward
- 20.35x
- P/E 2026E
- 21.70x
- P/E 2027E
- 19.33x
- P/E 2028E
- 16.97x
- P/S forward
- 2.31x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.84x
- Price / sales
- 2.42x
- Price / cash flow
- 19.68x
Enterprise value
- Enterprise value
- $15.5B
- EV / sales
- 3.09x
- EV / EBITDA
- 20.07x
- EV / EBIT
- 33.62x
- Market cap
- $12.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026